https://nordiclifescience.org/cantargia-reports-new-promising-data/
Cantargia reports new promising data - NLS
Sep 16, 2024 - Cantargia has reported data providing insights to the mechanisms underlying the antitumor activity of the IL1RAP-binding antibody nadunolimab.
cantargiareportsnewpromisingdata
https://www.vinge.se/en/mandates/vinge-advises-cantargia-in-connection-with-rights-issue-1/
Vinge advises Cantargia in connection with rights issue
Vinge advises Cantargia AB (publ) in connection with a rights issue of approximately SEK 170 million.
in connectionrights issuevingeadvisescantargia
https://www.hl.co.uk/shares/shares-search-results/c/cantargia-ab-npv/company-information
Cantargia AB (CANTA) Company Information
Company information for Cantargia AB (CANTA) including general stock details, key personnel and important dates for your diary.
company informationcantargiaab